ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Healy Confirmed As NIH Director; States Priorities

April 5, 1991

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005

A Transcript: what Fisher Knew, When Did He Know

June 24, 1994

Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It

September 19, 1980

NCI-Approved Clinical Trials

September 29, 2006

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013